These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7206594)

  • 21. Hepatoerythropoietic porphyria: clinical, biochemical, and enzymatic studies in a three-generation family lineage.
    Toback AC; Sassa S; Poh-Fitzpatrick MB; Schechter J; Zaider E; Harber LC; Kappas A
    N Engl J Med; 1987 Mar; 316(11):645-50. PubMed ID: 3821794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.
    Elder GH; Sheppard DM; De Salamanca RE; Olmos A
    Clin Sci (Lond); 1980 Jun; 58(6):477-84. PubMed ID: 7428280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Decreased erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda].
    Kondo M
    Nihon Hifuka Gakkai Zasshi; 1985 Aug; 95(9):995-6. PubMed ID: 4079084
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.
    Elder GH; Sheppard DM; Tovey JA; Urquhart AJ
    Lancet; 1983 Jun; 1(8337):1301-4. PubMed ID: 6134095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The enzymatic defects in porphyria cutanea tarda and variegate porphyria.
    Kushner JP
    Acta Derm Venereol Suppl (Stockh); 1982; 100():51-6. PubMed ID: 6962633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and properties of human erythrocyte uroporphyrinogen decarboxylase: immunological demonstration of the enzyme defect in porphyria cutanea tarda.
    Sassa S; de Verneuil H; Anderson KE; Kappas A
    Trans Assoc Am Physicians; 1983; 96():65-75. PubMed ID: 6437037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial porphyria cutanea tarda: the pattern of porphyrins formed from porphobilinogen by hemolysates.
    Alleman MA; Wilson JH; van den Berg JW; Edixhoven-Bosdijk A; van Gastel-Quist LM
    Clin Chem; 1982 May; 28(5):1144-7. PubMed ID: 7074894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene.
    Elder GH; Sheppard DM
    Biochem Biophys Res Commun; 1982 Nov; 109(1):113-20. PubMed ID: 7159416
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects.
    Elder GH; Roberts AG; de Salamanca RE
    Clin Biochem; 1989 Jun; 22(3):163-8. PubMed ID: 2786774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda and in other forms of porphyria.
    Felsher BF; Norris ME; Shih JC
    N Engl J Med; 1978 Nov; 299(20):1095-8. PubMed ID: 703786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New form of dual porphyria: coexistent acute intermittent porphyria and porphyria cutanea tarda.
    Doss MO
    Eur J Clin Invest; 1989 Feb; 19(1):20-5. PubMed ID: 2499457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of familial porphyria cutanea tarda.
    Roberts AG; Elder GH; Newcombe RG; Enriquez de Salamanca R; Munoz JJ
    J Med Genet; 1988 Oct; 25(10):669-76. PubMed ID: 3225822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda.
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1985 Mar; 127(2):517-25. PubMed ID: 3977935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assay of uroporphyrinogen decarboxylase in erythrocytes.
    McManus J; Blake D; Ratnaike S
    Clin Chem; 1988 Nov; 34(11):2355-7. PubMed ID: 3180434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective human erythrocyte uroporphyrinogen decarboxylase in familial porphyria cutanea tarda: the metabolic lesion or the result of endogenous porphyrinemia?
    Mukerji SK; Pimstone NR
    Biochem Biophys Res Commun; 1988 Jul; 154(1):39-46. PubMed ID: 3395340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The porphyria cutanea tarda group: their role among the enzyme defects of heme biosynthesis].
    Adrien A; Guillet G
    Sem Hop; 1984 Apr; 60(16):1148-52. PubMed ID: 6326308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital erythropoietic porphyria, diminished activity of uroporphyrinogen decarboxylase and dyserythropoiesis.
    Kushner JP; Pimstone NR; Kjeldsberg CR; Pryor MA; Huntley A
    Blood; 1982 Apr; 59(4):725-37. PubMed ID: 7059676
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of chronic hepatic porphyria (porphyria cutanea tarda) with inherited uroporphyrinogen decarboxylase deficiency under exposure to dioxin.
    Doss M; Sauer H; von Tiepermann R; Colombi AM
    Int J Biochem; 1984; 16(4):369-73. PubMed ID: 6714509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme defects in hereditary porphyria.
    Civin WH; Epstein E
    Ann Clin Lab Sci; 1980; 10(5):395-401. PubMed ID: 6999973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?
    Elder GH; Smith SG; Herrero C; Lecha M; Mascaro JM; Muniesa AM; Czarnecki DB; Brenan J; Poulos V; DE Salamanca RE
    Lancet; 1981 Apr; 1(8226):916-9. PubMed ID: 6112327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.